Phase 2 Hemophilia A Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency
Hemophilia AHemophilia BFactor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd.76 enrolled9 locationsNCT07644832
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Hemophilia A
Hoffmann-La Roche60 enrolled14 locationsNCT05987449
Recruiting
Phase 1Phase 2
A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Hemophilia A
Hoffmann-La Roche5 enrolled2 locationsNCT07226206
Recruiting
Phase 2Phase 3
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.55 enrolled10 locationsNCT06111638
Recruiting
Phase 1Phase 2
ASC618 Gene Therapy in Hemophilia A Patients
Hemophilia A
ASC Therapeutics12 enrolled1 locationNCT04676048